ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 155 filers reported holding ATARA BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,389,985 | -14.4% | 7,695,935 | -6.9% | 0.00% | – |
| Q2 2023 | $13,303,832 | -50.5% | 8,263,249 | -10.9% | 0.00% | -100.0% |
| Q1 2023 | $26,886,765 | -10.4% | 9,271,298 | +1.3% | 0.00% | 0.0% |
| Q4 2022 | $30,019,050 | -10.9% | 9,152,149 | +2.7% | 0.00% | 0.0% |
| Q3 2022 | $33,686,000 | -50.7% | 8,911,991 | +1.7% | 0.00% | -50.0% |
| Q2 2022 | $68,279,000 | -5.8% | 8,764,706 | +12.4% | 0.00% | 0.0% |
| Q1 2022 | $72,461,000 | -41.2% | 7,800,139 | -0.2% | 0.00% | -33.3% |
| Q4 2021 | $123,190,000 | -10.1% | 7,816,552 | +2.2% | 0.00% | -25.0% |
| Q3 2021 | $136,963,000 | +14.1% | 7,651,591 | -0.9% | 0.00% | +33.3% |
| Q2 2021 | $120,047,000 | +20.3% | 7,720,031 | +11.1% | 0.00% | 0.0% |
| Q1 2021 | $99,790,000 | -21.2% | 6,949,109 | +7.7% | 0.00% | -25.0% |
| Q4 2020 | $126,700,000 | +65.9% | 6,454,415 | +9.5% | 0.00% | +33.3% |
| Q3 2020 | $76,362,000 | +2.1% | 5,891,976 | +14.8% | 0.00% | 0.0% |
| Q2 2020 | $74,761,000 | +92.4% | 5,131,251 | +12.4% | 0.00% | +50.0% |
| Q1 2020 | $38,851,000 | -48.5% | 4,565,283 | -0.3% | 0.00% | -33.3% |
| Q4 2019 | $75,438,000 | +20.1% | 4,580,414 | +3.0% | 0.00% | 0.0% |
| Q3 2019 | $62,815,000 | -18.7% | 4,448,656 | +15.8% | 0.00% | 0.0% |
| Q2 2019 | $77,252,000 | -44.2% | 3,841,451 | +10.2% | 0.00% | -50.0% |
| Q1 2019 | $138,507,000 | +13.5% | 3,484,425 | -0.8% | 0.01% | 0.0% |
| Q4 2018 | $122,050,000 | -15.4% | 3,513,235 | +0.6% | 0.01% | 0.0% |
| Q3 2018 | $144,345,000 | +16.7% | 3,490,782 | +3.8% | 0.01% | 0.0% |
| Q2 2018 | $123,650,000 | +11.5% | 3,364,604 | +18.3% | 0.01% | +20.0% |
| Q1 2018 | $110,934,000 | +212.3% | 2,844,441 | +45.0% | 0.01% | +150.0% |
| Q4 2017 | $35,517,000 | +7.7% | 1,962,261 | -1.5% | 0.00% | 0.0% |
| Q3 2017 | $32,978,000 | +22.5% | 1,992,643 | +3.6% | 0.00% | +100.0% |
| Q2 2017 | $26,929,000 | -24.1% | 1,923,515 | +11.4% | 0.00% | -50.0% |
| Q1 2017 | $35,474,000 | +19941.8% | 1,726,197 | +13727.3% | 0.00% | – |
| Q4 2016 | $177,000 | -34.9% | 12,484 | -1.7% | 0.00% | – |
| Q3 2016 | $272,000 | +98.5% | 12,697 | +108.1% | 0.00% | – |
| Q2 2016 | $137,000 | +585.0% | 6,100 | +464.3% | 0.00% | – |
| Q1 2016 | $20,000 | +53.8% | 1,081 | +120.2% | 0.00% | – |
| Q4 2015 | $13,000 | -59.4% | 491 | -52.2% | 0.00% | – |
| Q3 2015 | $32,000 | +88.2% | 1,027 | +214.1% | 0.00% | – |
| Q2 2015 | $17,000 | +183.3% | 327 | +120.9% | 0.00% | – |
| Q1 2015 | $6,000 | +50.0% | 148 | 0.0% | 0.00% | – |
| Q4 2014 | $4,000 | – | 148 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XV Associates, LLC | 1,876,650 | $29,182,000 | 13.03% |
| Copernicus Capital Management, LLC | 50,000 | $778,000 | 12.27% |
| Antipodean Advisors LLC | 1,000,000 | $15,550,000 | 4.28% |
| BRIDGER MANAGEMENT, LLC | 1,325,188 | $20,607,000 | 1.92% |
| Redmile Group, LLC | 6,449,577 | $100,291,000 | 1.48% |
| MAVERICK CAPITAL LTD | 7,704,676 | $119,808,000 | 1.12% |
| Baupost Group | 8,477,488 | $131,825,000 | 1.07% |
| ACT CAPITAL MANAGEMENT, LLC | 116,900 | $1,818,000 | 0.93% |
| Trellus Management Company, LLC | 73,056 | $1,136,000 | 0.78% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $8,164,000 | 0.75% |